SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Female Health FHCO
An SI Board Since November 2010
Posts SubjectMarks Bans Symbol
211 6 0 VERU
Emcee:  Savant Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
161VERU Oct 21 $10 puts were available to sell for $3.80Savant-9/7/2022
160VERU went down and filled the gap from 11.77... fwiwSavant-9/7/2022
159Veru to Present at the H.C. Wainwright 24th Annual Global Investment ConferSavant-9/7/2022
158Veru Granted Expedited Provisional Registration Regulatory Pathway for SabizabulSavant-8/24/2022
157Veru Inc. (VERU) is currently at $23.34, @2:36 --Would be highest close sSavant-8/16/2022
156VERU Whopping Mortality Benefit in Severe COVID Trial — Oral sabizabulin showeSavant-7/8/2022
155VERU EUA submitted to FDA for antiviral Covid drug... up 18%Savant-6/7/2022
154Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease FSavant-5/18/2022
153VERU U.S. Food and Drug Administration has agreed that the biopharmaceutical Savant-5/13/2022
152VERU $17.50 hi tdy, before selling off...still v. hi volSavant-4/14/2022
151VERU Veru Inc VERU +151.03% (Get Free Alerts for VERU) shares are trading sigSavant-4/11/2022
150*more.... In addition, sabizabulin, which has dual antiviral and anti-iSavant-2/1/2022
149Veru Enters into Clinical Trial Collaboration and Supply Agreement with EliSavant-2/1/2022
148Veru Inc. said the U.S. Food and Drug Administration has granted fast trackSavant-2/1/2022
147Veru Inc. shares were up 14% to $6.08 Tuesday, one day after the company saSavant-1/11/2022
146Veru Announces FDA Approval of ENTADFI, a New Treatment for Benign ProstatiSavant-12/13/2021
145Veru Reports Record Fiscal 2021 Full-Year Financial Results --FY21 Net RevSavant-12/6/2021
144Veru Ranked as one of the Fastest-Growing Companies in North America on theSavant-11/19/2021
143Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial oSavant-11/8/2021
142Veru Announces Acceptance of Two Abstracts for Presentation at the American SociSavant-5/24/2021
141VERU NDA & more Veru Submits New Drug Application for Proprietary TADFIN foSavant-2/23/2021
140Veru Inc (NASDAQ: VERU) priced its underwritten public offering of 6.5 millionSavant-2/18/2021
139[graphic]Savant-2/17/2021
138VERU TADFIN new drug app to be submitted to FDA next week//also earnings out, Savant-2/10/2021
137VERU hit $24.57 up over 68%Savant-2/9/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News